Connection

Miguel Abboud to Humans

Back to Details
This is a "connection" page, showing publications Miguel Abboud has written about Humans.
Miguel Abboud
Connection Strength
1.271
Humans
  1. Sickle cell disease care in Lebanon: resource-constrained and humanitarian crisis adaptations. Lancet Haematol. 2023 02; 10(2):e91-e92.
    View in: PubMed
    Score: 0.033
  2. Voxelotor for the treatment of sickle cell disease in pediatric patients. Expert Rev Hematol. 2022 06; 15(6):485-492.
    View in: PubMed
    Score: 0.031
  3. The Spectrum of ?-Thalassemia Mutations in the Population Migration in Lebanon: A 6-Year Retrospective Study. Hemoglobin. 2021 Nov; 45(6):365-370.
    View in: PubMed
    Score: 0.029
  4. Emergence of gram-negative organisms as the cause of infections in patients with sickle cell disease. Pediatr Blood Cancer. 2021 01; 68(1):e28784.
    View in: PubMed
    Score: 0.028
  5. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev. 2020 04 06; 4:CD012389.
    View in: PubMed
    Score: 0.027
  6. Standard management of sickle cell disease complications. Hematol Oncol Stem Cell Ther. 2020 Jun; 13(2):85-90.
    View in: PubMed
    Score: 0.027
  7. Acquired centromeric heteromorphism of chromosome 7 yields discordant results between fluorescent in situ hybridization and karyotype analysis in a child with severe congenital neutropenia. Pediatr Hematol Oncol. 2019 Oct; 36(7):432-437.
    View in: PubMed
    Score: 0.026
  8. Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon. J Glob Oncol. 2019 04; 5:1-8.
    View in: PubMed
    Score: 0.025
  9. Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Curr Res Transl Med. 2017 09; 65(3):115-119.
    View in: PubMed
    Score: 0.023
  10. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev. 2017 05 13; 5:CD012389.
    View in: PubMed
    Score: 0.022
  11. Sickle cell disease. Lancet. 2017 07 15; 390(10091):311-323.
    View in: PubMed
    Score: 0.022
  12. The Daily Experiences of Adolescents in Lebanon With Sickle Cell Disease. J Pediatr Health Care. 2015 Sep-Oct; 29(5):424-34.
    View in: PubMed
    Score: 0.019
  13. Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results. Curr Opin Oncol. 2014 Nov; 26(6):650-5.
    View in: PubMed
    Score: 0.019
  14. Alpha thalassemia allelic frequency in Lebanon. Pediatr Blood Cancer. 2015 Jan; 62(1):120-2.
    View in: PubMed
    Score: 0.018
  15. Educational intervention to improve the health outcomes of children with sickle cell disease. J Pediatr Health Care. 2015 Jan-Feb; 29(1):54-60.
    View in: PubMed
    Score: 0.018
  16. Quality of palliative care in children with cancer in Lebanon. J Med Liban. 2013 Oct-Dec; 61(4):228-36.
    View in: PubMed
    Score: 0.017
  17. Intracranial blood flow velocities in patients with sickle cell disease and ?-thalassemia intermedia. Am J Hematol. 2013 Sep; 88(9):825.
    View in: PubMed
    Score: 0.017
  18. Delayed initiation of front-line imatinib therapy predicts for poor response to nilotinib as second-line treatment of imatinib-resistant or intolerant CML: single center report of the ENACT trial in Lebanon. Int J Hematol. 2012 Oct; 96(4):521-4.
    View in: PubMed
    Score: 0.016
  19. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am J Hematol. 2012 Jul; 87(7):678-83.
    View in: PubMed
    Score: 0.016
  20. Pulmonary complications of sickle cell disease. Hemoglobin. 2011; 35(5-6):625-35.
    View in: PubMed
    Score: 0.015
  21. Cerebral infarction in children with sickle cell disease: a concise overview. Hemoglobin. 2011; 35(5-6):618-24.
    View in: PubMed
    Score: 0.015
  22. Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood. 2011 Jul 28; 118(4):894-8.
    View in: PubMed
    Score: 0.015
  23. Stem-cell transplantation in children and adults with sickle cell disease: an update. Expert Rev Hematol. 2011 Jun; 4(3):343-51.
    View in: PubMed
    Score: 0.015
  24. Predictors of bone loss in childhood hematologic malignancies: a prospective study. Osteoporos Int. 2012 Feb; 23(2):665-74.
    View in: PubMed
    Score: 0.015
  25. Bereaved parental evaluation of the quality of a palliative care program in Lebanon. Pediatr Blood Cancer. 2011 Aug; 57(2):310-6.
    View in: PubMed
    Score: 0.014
  26. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease. Pediatr Blood Cancer. 2010 Dec 15; 55(7):1338-42.
    View in: PubMed
    Score: 0.014
  27. L-asparaginase-induced pancreatitis in children with acute lymphoblastic leukemia: is allopurinol protective? Pediatr Hematol Oncol. 2010 Sep; 27(6):496-501.
    View in: PubMed
    Score: 0.014
  28. Wernicke's encephalopathy during total parenteral nutrition in a child with acute lymphoblastic leukemia and acute pancreatitis. Neuropediatrics. 2009 Oct; 40(5):249-51.
    View in: PubMed
    Score: 0.013
  29. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr Blood Cancer. 2010 Mar; 54(3):398-402.
    View in: PubMed
    Score: 0.013
  30. Hematopoietic stem-cell transplantation for adults with sickle cell disease. N Engl J Med. 2009 Dec 10; 361(24):2380-1.
    View in: PubMed
    Score: 0.013
  31. Renal venous thrombosis in a newborn with prothrombotic risk factors. Blood Coagul Fibrinolysis. 2009 Sep; 20(6):458-60.
    View in: PubMed
    Score: 0.013
  32. Limb salvage surgery for children and adolescents with malignant bone tumors in a developing country. Pediatr Blood Cancer. 2008 Dec; 51(6):787-91.
    View in: PubMed
    Score: 0.012
  33. Venous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: treatment with thrombolysis. Am J Hematol. 2008 Oct; 83(10):818-20.
    View in: PubMed
    Score: 0.012
  34. Iron deficiency in young Lebanese children: association with elevated blood lead levels. J Pediatr Hematol Oncol. 2008 May; 30(5):382-6.
    View in: PubMed
    Score: 0.012
  35. Spontaneous splenic rupture in a patient with factor XIII deficiency and a novel mutation. Pediatr Blood Cancer. 2008 Jan; 50(1):113-4.
    View in: PubMed
    Score: 0.012
  36. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels. Pediatr Blood Cancer. 2008 Jan; 50(1):62-5.
    View in: PubMed
    Score: 0.012
  37. Primary malignant peripheral nerve sheath tumor of the lung in a young child without neurofibromatosis type 1. Pediatr Blood Cancer. 2006 Oct 15; 47(5):636-8.
    View in: PubMed
    Score: 0.011
  38. Prevention and management of strokes in patients with sickle cell disease. Curr Hematol Rep. 2006 Mar; 5(1):15-22.
    View in: PubMed
    Score: 0.010
  39. Radiographic predictors of neurocognitive functioning in pediatric Sickle Cell disease. J Child Neurol. 2006 Jan; 21(1):37-44.
    View in: PubMed
    Score: 0.010
  40. Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience. J Pediatr Hematol Oncol. 2004 Nov; 26(11):749-53.
    View in: PubMed
    Score: 0.009
  41. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood. 2004 Apr 01; 103(7):2822-6.
    View in: PubMed
    Score: 0.009
  42. Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study. Blood. 2022 09 29; 140(13):1470-1481.
    View in: PubMed
    Score: 0.008
  43. Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle-income country. Pediatr Blood Cancer. 2022 11; 69(11):e29982.
    View in: PubMed
    Score: 0.008
  44. Causes of New-Onset Seizures and Their Treatment in Children With Non-CNS Malignancies: A Retrospective Study in a Tertiary Care Center. Pediatr Neurol. 2022 12; 137:17-21.
    View in: PubMed
    Score: 0.008
  45. Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11?years. Pediatr Blood Cancer. 2022 08; 69(8):e29716.
    View in: PubMed
    Score: 0.008
  46. Diagnosis and Treatment of a Patient With Severe Combined Immunodeficiency Due to a Novel Homozygous Mutation in the IL-7Ra Chain. Front Immunol. 2022; 13:867837.
    View in: PubMed
    Score: 0.008
  47. Vincristine-induced neurotoxicity in pediatric patients with rhabdomyosarcoma: A retrospective analysis of clinical features and outcome. Pediatr Hematol Oncol. 2022 Oct; 39(7):644-649.
    View in: PubMed
    Score: 0.008
  48. Long-term follow-up of children treated with the Repiphysis expandable prosthesis for lower extremity bone sarcoma. J Pediatr Orthop B. 2022 Mar 01; 31(2):e258-e263.
    View in: PubMed
    Score: 0.008
  49. Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. Pediatr Blood Cancer. 2021 11; 68(11):e29210.
    View in: PubMed
    Score: 0.007
  50. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Haematol. 2021 May; 8(5):e334-e343.
    View in: PubMed
    Score: 0.007
  51. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA. 2021 04 20; 325(15):1513-1523.
    View in: PubMed
    Score: 0.007
  52. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol. 2021 04 01; 96(4):404-417.
    View in: PubMed
    Score: 0.007
  53. Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24?months. Pediatr Blood Cancer. 2021 05; 68(5):e28977.
    View in: PubMed
    Score: 0.007
  54. Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived From Structural and Functional Analysis of 14 ClC-7 Mutants. J Bone Miner Res. 2021 03; 36(3):531-545.
    View in: PubMed
    Score: 0.007
  55. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol. 2000 Nov; 111(2):482-90.
    View in: PubMed
    Score: 0.007
  56. Epidemiology and clinical characteristics of viral infections in hospitalized children and adolescents with cancer in Lebanon. PLoS One. 2020; 15(9):e0239258.
    View in: PubMed
    Score: 0.007
  57. Wiskott-Aldrich Syndrome in four male siblings from a consanguineous family from Lebanon. Clin Immunol. 2020 10; 219:108573.
    View in: PubMed
    Score: 0.007
  58. Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon. J Pediatr Hematol Oncol. 2020 08; 42(6):e428-e433.
    View in: PubMed
    Score: 0.007
  59. Port-a-Cath fracture and migration in paediatric cancer patients: incidence and management at a tertiary care centre - a 15-year experience. Cardiol Young. 2020 Jul; 30(7):986-990.
    View in: PubMed
    Score: 0.007
  60. Paediatric to adult transition care for patients with sickle cell disease: a global perspective. Lancet Haematol. 2020 Apr; 7(4):e329-e341.
    View in: PubMed
    Score: 0.007
  61. Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT). Bone Marrow Transplant. 2020 07; 55(7):1485-1490.
    View in: PubMed
    Score: 0.007
  62. The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience. Eur J Radiol. 2020 Mar; 124:108855.
    View in: PubMed
    Score: 0.007
  63. Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3). Contemp Clin Trials. 2019 10; 85:105835.
    View in: PubMed
    Score: 0.006
  64. Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome. Pediatr Blood Cancer. 2019 11; 66(11):e27959.
    View in: PubMed
    Score: 0.006
  65. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
    View in: PubMed
    Score: 0.006
  66. Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme patients: A single-center experience in the Middle East region. Clin Neurol Neurosurg. 2019 07; 182:92-97.
    View in: PubMed
    Score: 0.006
  67. Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study. Br J Haematol. 2019 01; 184(2):269-278.
    View in: PubMed
    Score: 0.006
  68. Isolated delayed metastasis to the talus from Ewing's sarcoma. J Radiol Case Rep. 2018 Aug; 12(8):17-24.
    View in: PubMed
    Score: 0.006
  69. Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. Bone Marrow Transplant. 2019 03; 54(3):402-417.
    View in: PubMed
    Score: 0.006
  70. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Pharmacogenet Genomics. 2018 08; 28(8):189-195.
    View in: PubMed
    Score: 0.006
  71. The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2. Haematologica. 2018 12; 103(12):2008-2015.
    View in: PubMed
    Score: 0.006
  72. Granulocytosis causing sickle-cell crisis. Lancet. 1998 Mar 28; 351(9107):959.
    View in: PubMed
    Score: 0.006
  73. Displaced children with cancer in Lebanon: A sustained response to an unprecedented crisis. Cancer. 2018 04 01; 124(7):1464-1472.
    View in: PubMed
    Score: 0.006
  74. Routine surveillance imaging after end of therapy for pediatric extracranial tumors: A retrospective analysis. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.006
  75. Pediatric cancer pathology review from a single institution: Neuropathology expert opinion is essential for accurate diagnosis of pediatric brain tumors. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.006
  76. Renal Medullary Carcinoma: Establishing Standards in Practice. J Oncol Pract. 2017 07; 13(7):414-421.
    View in: PubMed
    Score: 0.006
  77. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. Pediatr Blood Cancer. 2017 Dec; 64(12).
    View in: PubMed
    Score: 0.006
  78. Trends in hematopoietic stem cell transplant activity in Lebanon. Hematol Oncol Stem Cell Ther. 2017 Dec; 10(4):315-320.
    View in: PubMed
    Score: 0.006
  79. Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes. Nat Genet. 2017 May; 49(5):742-752.
    View in: PubMed
    Score: 0.005
  80. Transient therapy-related myelodysplastic syndrome associated with monosomy 7 and 11q23 translocation. Leukemia. 1997 Mar; 11(3):448-50.
    View in: PubMed
    Score: 0.005
  81. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group. Bone Marrow Transplant. 2017 Jan; 52(1):120-125.
    View in: PubMed
    Score: 0.005
  82. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon. Pediatr Blood Cancer. 2017 01; 64(1):146-150.
    View in: PubMed
    Score: 0.005
  83. Neurologic complications following bone marrow transplantation for sickle cell disease. Bone Marrow Transplant. 1996 Mar; 17(3):405-7.
    View in: PubMed
    Score: 0.005
  84. Effect of Malnutrition at Diagnosis on Clinical Outcomes of Children With Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2016 Mar; 38(2):107-10.
    View in: PubMed
    Score: 0.005
  85. Serum levels of GM-CSF are elevated in patients with thrombocytopenia. Br J Haematol. 1996 Feb; 92(2):486-8.
    View in: PubMed
    Score: 0.005
  86. Wilms tumor: Successes and challenges in management outside of cooperative clinical trials. Hematol Oncol Stem Cell Ther. 2016 Mar; 9(1):20-5.
    View in: PubMed
    Score: 0.005
  87. Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis. Genome Med. 2015 Dec 18; 7:130.
    View in: PubMed
    Score: 0.005
  88. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events. N Engl J Med. 2016 Feb 18; 374(7):625-35.
    View in: PubMed
    Score: 0.005
  89. Effects of CD34+ selection and T cell immunodepletion on cord blood hematopoietic progenitors: relevance to stem cell transplantation. Exp Hematol. 1995 Dec; 23(14):1492-6.
    View in: PubMed
    Score: 0.005
  90. Approach to Non-Neutropenic Fever in Pediatric Oncology Patients-A Single Institution Study. Pediatr Blood Cancer. 2015 Dec; 62(12):2167-71.
    View in: PubMed
    Score: 0.005
  91. 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Pediatr Blood Cancer. 2015 Aug; 62(8):1427-36.
    View in: PubMed
    Score: 0.005
  92. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation. Bone Marrow Transplant. 1995 Feb; 15(2):187-92.
    View in: PubMed
    Score: 0.005
  93. Pain in children and adolescents with sickle cell anemia: a prospective study utilizing self-reporting. Am J Pediatr Hematol Oncol. 1994 Aug; 16(3):219-24.
    View in: PubMed
    Score: 0.005
  94. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2014 Aug; 24(8):387-96.
    View in: PubMed
    Score: 0.005
  95. A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2014 Jul; 89(7):709-13.
    View in: PubMed
    Score: 0.004
  96. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med. 2014 Mar 12; 6(227):227ra33.
    View in: PubMed
    Score: 0.004
  97. Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon. Leuk Lymphoma. 2014 Aug; 55(8):1918-21.
    View in: PubMed
    Score: 0.004
  98. Bone marrow transplantation for sickle cell disease. The United States experience. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):22-6.
    View in: PubMed
    Score: 0.004
  99. Bone marrow transplantation for sickle cell anemia. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):86-9.
    View in: PubMed
    Score: 0.004
  100. Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon. Pediatr Blood Cancer. 2014 Aug; 61(8):1472-5.
    View in: PubMed
    Score: 0.004
  101. Priapism, an emerging complication in ?-thalassemia intermedia patients. Hemoglobin. 2014; 38(5):351-4.
    View in: PubMed
    Score: 0.004
  102. [Analysis of the quality of data issued from Beirut's hospitals in order to measure short-term health effects of air pollution]. Rev Epidemiol Sante Publique. 2013 Dec; 61(6):551-8.
    View in: PubMed
    Score: 0.004
  103. A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2013 Nov; 88(11):E255-60.
    View in: PubMed
    Score: 0.004
  104. Setting practice standards for palliative care in Lebanon--recommendations of the Subcommittee on Practice --National Committee for Pain Control and Palliative Care. J Med Liban. 2013 Oct-Dec; 61(4):199-203.
    View in: PubMed
    Score: 0.004
  105. Spiny follicular hyperkeratotic papules on the face. JAMA Pediatr. 2013 Sep; 167(9):867-8.
    View in: PubMed
    Score: 0.004
  106. Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution. J Pediatr Hematol Oncol. 2013 Jul; 35(5):356-60.
    View in: PubMed
    Score: 0.004
  107. Complete heart block in a patient with acute lymphoblastic leukaemia: teicoplanin as a possible cause and review of literature. J Clin Pharm Ther. 2013 Apr; 38(2):156-8.
    View in: PubMed
    Score: 0.004
  108. Effects of radiation and 4-hydroperoxycyclophosphamide on production of G- and GM-CSF by stromal cells. Bone Marrow Transplant. 1992 Dec; 10(6):529-33.
    View in: PubMed
    Score: 0.004
  109. Study of early hematopoietic precursors in human cord blood. Exp Hematol. 1992 Oct; 20(9):1043-7.
    View in: PubMed
    Score: 0.004
  110. Rhabdomyosarcoma treatment and outcome at a multidisciplinary pediatric cancer center in Lebanon. Pediatr Hematol Oncol. 2012 May; 29(4):322-34.
    View in: PubMed
    Score: 0.004
  111. Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing's sarcoma. Skeletal Radiol. 2012 Nov; 41(11):1453-61.
    View in: PubMed
    Score: 0.004
  112. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma. J Bone Joint Surg Br. 2012 Mar; 94(3):419-24.
    View in: PubMed
    Score: 0.004
  113. Inherited thrombophilia in childhood arterial stroke: data from Lebanon. Pediatr Neurol. 2011 Sep; 45(3):155-8.
    View in: PubMed
    Score: 0.004
  114. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models. Pediatr Hematol Oncol. 2011 Nov; 28(8):676-81.
    View in: PubMed
    Score: 0.004
  115. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis. 2011 Aug 15; 47(2):125-8.
    View in: PubMed
    Score: 0.004
  116. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group. Hematol Oncol Stem Cell Ther. 2011; 4(2):81-93.
    View in: PubMed
    Score: 0.004
  117. Complementary and alternative medicine use among pediatric patients with leukemia: the case of Lebanon. Integr Cancer Ther. 2011 Mar; 10(1):38-46.
    View in: PubMed
    Score: 0.004
  118. Y-chromosome R-M343 African lineages and sickle cell disease reveal structured assimilation in Lebanon. J Hum Genet. 2011 Jan; 56(1):29-33.
    View in: PubMed
    Score: 0.004
  119. Seven-year experience of using Repiphysis expandable prosthesis in children with bone tumors. Pediatr Blood Cancer. 2010 Sep; 55(3):457-63.
    View in: PubMed
    Score: 0.003
  120. Vascular at-risk genotypes and disease severity in Lebanese sickle cell disease patients. Am J Hematol. 2010 May; 85(5):395-6.
    View in: PubMed
    Score: 0.003
  121. Severe cerebral vaso-occlusive disease in macrophage activation syndrome. Pediatr Neurol. 2010 Apr; 42(4):283-6.
    View in: PubMed
    Score: 0.003
  122. Zinc and biotin deficiencies after pancreaticoduodenectomy. Acta Gastroenterol Belg. 2010 Apr-Jun; 73(2):283-6.
    View in: PubMed
    Score: 0.003
  123. Morvan syndrome following B-cell lymphoma. J Child Neurol. 2010 Aug; 25(8):1038-41.
    View in: PubMed
    Score: 0.003
  124. Endobronchial metastasis of osteosarcoma presenting as position-dependent and variable airway obstruction of the trachea. Thorax. 2010 Jan; 65(1):92.
    View in: PubMed
    Score: 0.003
  125. The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J. 2010; 30:80-3.
    View in: PubMed
    Score: 0.003
  126. Modeling pathways for low bone mass in children with malignancies. J Clin Densitom. 2009 Oct-Dec; 12(4):441-9.
    View in: PubMed
    Score: 0.003
  127. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution. Pediatr Hematol Oncol. 2009 Sep; 26(6):439-47.
    View in: PubMed
    Score: 0.003
  128. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009 Nov 19; 114(21):4632-8.
    View in: PubMed
    Score: 0.003
  129. Abdominal complications of chemotherapy in pediatric malignancies: imaging findings. Clin Imaging. 2009 Jul-Aug; 33(4):253-60.
    View in: PubMed
    Score: 0.003
  130. First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate. Pediatr Blood Cancer. 2009 Feb; 52(2):308.
    View in: PubMed
    Score: 0.003
  131. Sickle cell disease at the dawn of the molecular era. Hemoglobin. 2009; 33 Suppl 1:S93-S106.
    View in: PubMed
    Score: 0.003
  132. Familial infantile pyknocytosis in association with pulmonary hypertension. Pediatr Blood Cancer. 2008 Aug; 51(2):290-2.
    View in: PubMed
    Score: 0.003
  133. Hematopoietic stem cell transplantation in Lebanon: first comprehensive report. Bone Marrow Transplant. 2008 Aug; 42 Suppl 1:S96-S102.
    View in: PubMed
    Score: 0.003
  134. Chemical and functional analysis of generic hydroxyurea formulations. Pediatr Hematol Oncol. 2008 Jun; 25(5):423-9.
    View in: PubMed
    Score: 0.003
  135. Addition of ketamine to propofol for initiation of procedural anesthesia in children reduces propofol consumption and preserves hemodynamic stability. Acta Anaesthesiol Scand. 2008 Apr; 52(4):561-5.
    View in: PubMed
    Score: 0.003
  136. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children. Neuropediatrics. 2008 Feb; 39(1):46-50.
    View in: PubMed
    Score: 0.003
  137. Autoimmune neutropenia of childhood. Crit Rev Oncol Hematol. 1987; 7(1):37-51.
    View in: PubMed
    Score: 0.003
  138. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol. 2007 Jan; 136(2):343-4.
    View in: PubMed
    Score: 0.003
  139. Assessing procedural pain in children with cancer in Beirut, Lebanon. J Pediatr Oncol Nurs. 2006 Nov-Dec; 23(6):311-20.
    View in: PubMed
    Score: 0.003
  140. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. J Pediatr Hematol Oncol. 2006 Mar; 28(3):147-53.
    View in: PubMed
    Score: 0.003
  141. Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin. 2006; 30(2):165-70.
    View in: PubMed
    Score: 0.003
  142. Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients. Acta Neurochir (Wien). 2006 Feb; 148(2):175-9; discussion 180.
    View in: PubMed
    Score: 0.003
  143. Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. J Pediatr. 1985 Oct; 107(4):537-41.
    View in: PubMed
    Score: 0.002
  144. Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. Hemoglobin. 2004 May; 28(2):85-102.
    View in: PubMed
    Score: 0.002
  145. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
    View in: PubMed
    Score: 0.002
  146. Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics. 2003 Aug; 112(2):324-31.
    View in: PubMed
    Score: 0.002
  147. Report of a child with vitiligo and Evans syndrome. J Pediatr Hematol Oncol. 2003 Apr; 25(4):344-5.
    View in: PubMed
    Score: 0.002
  148. Effective treatment of hypereosinophilic syndrome with imatinib mesylate. Hematol J. 2003; 4(6):410-2.
    View in: PubMed
    Score: 0.002
  149. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001 Dec; 139(6):785-9.
    View in: PubMed
    Score: 0.002
  150. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):335-9.
    View in: PubMed
    Score: 0.002
  151. Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood. 2000 May 15; 95(10):3057-64.
    View in: PubMed
    Score: 0.002
  152. Use of amphotericin B colloidal dispersion in children. J Pediatr Hematol Oncol. 2000 May-Jun; 22(3):242-6.
    View in: PubMed
    Score: 0.002
  153. Interleukin 8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication. Arch Dis Child. 2000 Feb; 82(2):165-8.
    View in: PubMed
    Score: 0.002
  154. Costs, charges, and reimbursements for persons with sickle cell disease. J Pediatr Hematol Oncol. 1999 Sep-Oct; 21(5):389-96.
    View in: PubMed
    Score: 0.002
  155. Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics. Infection. 1999 May-Jun; 27(3):173-6.
    View in: PubMed
    Score: 0.002
  156. Postdural puncture headache in paediatric oncology patients. Can J Anaesth. 1998 Aug; 45(8):741-5.
    View in: PubMed
    Score: 0.002
  157. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11.
    View in: PubMed
    Score: 0.001
  158. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29.
    View in: PubMed
    Score: 0.001
  159. Survival with combined modality therapy after intracerebral recurrence of pleuropulmonary blastoma. Med Pediatr Oncol. 1998 Jan; 30(1):63-6.
    View in: PubMed
    Score: 0.001
  160. Successful treatment of relapsed infant acute lymphoblastic leukemia with intensive antimetabolite-based chemotherapy. Med Pediatr Oncol. 1997 Oct; 29(4):256-9.
    View in: PubMed
    Score: 0.001
  161. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997 Mar 01; 89(5):1533-42.
    View in: PubMed
    Score: 0.001
  162. Progressive autologous graft-versus-host disease induced by cyclosporin A. Bone Marrow Transplant. 1996 Sep; 18(3):659-62.
    View in: PubMed
    Score: 0.001
  163. Myelodysplasia associated with Turner syndrome. J Pediatr Hematol Oncol. 1996 Aug; 18(3):299-301.
    View in: PubMed
    Score: 0.001
  164. Characterization of c-kit expression by primitive hematopoietic progenitors in umbilical cord blood. Exp Hematol. 1995 Dec; 23(14):1515-9.
    View in: PubMed
    Score: 0.001
  165. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27; 333(4):206-13.
    View in: PubMed
    Score: 0.001
  166. Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. South Med J. 1995 Jul; 88(7):776-9.
    View in: PubMed
    Score: 0.001
  167. Adult Wilms' tumor: prognostic and management considerations. Urology. 1995 Jun; 45(6):1055-8.
    View in: PubMed
    Score: 0.001
  168. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9.
    View in: PubMed
    Score: 0.001
  169. Opsoclonus-myoclonus and recurrent neuroblastoma. J Pediatr. 1995 May; 126(5 Pt 1):847-8.
    View in: PubMed
    Score: 0.001
  170. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Exp Hematol. 1994 Dec; 22(13):1264-72.
    View in: PubMed
    Score: 0.001
  171. Effects of recombinant human Steel factor (c-kit ligand) on early cord blood hematopoietic precursors. Exp Hematol. 1994 Apr; 22(4):388-92.
    View in: PubMed
    Score: 0.001
  172. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol. 1994 Feb; 22(2):215-22.
    View in: PubMed
    Score: 0.001
  173. Impact of laparoscopic cholecystectomy on the management of cholelithiasis in children with sickle cell disease. J Pediatr Surg. 1994 Feb; 29(2):209-12; discussion 212-3.
    View in: PubMed
    Score: 0.001
  174. Measurement of marrow repopulating potential of human hematopoietic progenitor and stem cells using a fetal sheep model. Prog Clin Biol Res. 1994; 389:281-91.
    View in: PubMed
    Score: 0.001
  175. Ex vivo expansion of CD34+ cells from purified adult human bone marrow and umbilical cord blood hematopoietic progenitor cells. Prog Clin Biol Res. 1994; 389:385-91.
    View in: PubMed
    Score: 0.001
  176. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts? Blood Cells. 1994; 20(2-3):382-90; discussion 390-1.
    View in: PubMed
    Score: 0.001
  177. Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion. Radiology. 1993 Apr; 187(1):45-9.
    View in: PubMed
    Score: 0.001
  178. The state of the art in pediatric surgery and pediatric oncology at MUSC Children's Hospital. J S C Med Assoc. 1990 May; 86(5):290-3.
    View in: PubMed
    Score: 0.001
  179. High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. J Pediatr. 1990 Apr; 116(4):627-32.
    View in: PubMed
    Score: 0.001
  180. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989 06 15; 320(24):1574-80.
    View in: PubMed
    Score: 0.001
  181. Presence of tumour necrosis factor or a related factor in human basophil/mast cells. Immunology. 1989 Mar; 66(3):445-50.
    View in: PubMed
    Score: 0.001
  182. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Exp Hematol. 1989 Feb; 17(2):191-7.
    View in: PubMed
    Score: 0.001
  183. Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy. Biotherapy. 1989; 1(4):293-300.
    View in: PubMed
    Score: 0.001
  184. Five related Lebanese individuals with high plasma lysosomal hydrolases: a new defect in mannose-6-phosphate receptor recognition? Am J Hum Genet. 1984 Sep; 36(5):1001-14.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.